SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Idea: AAV Capsid Engineering for CNS-Targeted Neurodegeneration Th

idea 1,171 words KG: Aav 2026-03-29

kind:idea kind:therapy-idea section:ideas state:published evidence:strong

Contents

AAV Capsid Engineering for CNS-Targeted Neurodegeneration Therapy

Knowledge Graph

Related Hypotheses (30)

SASP-Mediated Complement Cascade Amplification
Score: 0.70 Nutrient-Sensing Epigenetic Circuit Reactivation
Score: 0.67 Transcriptional Autophagy-Lysosome Coupling
Score: 0.66 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63

Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Digital Twin-Guided Metabolic Reprogramming
Score: 0.61 Senescence-Activated NAD+ Depletion Rescue
Score: 0.60 Multi-Modal Stress Response Harmonization
Score: 0.60 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59 Circadian-Synchronized Proteostasis Enhancement
Score: 0.58 Microbial Inflammasome Priming Prevention
Score: 0.58 PARP1 Inhibition Therapy
Score: 0.58 AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.57 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Synthetic Biology BBB Endothelial Cell Reprogramming
Score: 0.57 SASP-Mediated Cholinergic Synapse Disruption
Score: 0.56 Selective HDAC3 Inhibition with Cognitive Enhancement
Score: 0.56 Smartphone-Detected Motor Variability Correction
Score: 0.56 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56 Adenosine-Astrocyte Metabolic Reset
Score: 0.56 Purinergic Signaling Polarization Control
Score: 0.55 Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.55 Blood-Brain Barrier SPM Shuttle System
Score: 0.55 Circadian Clock-Autophagy Synchronization
Score: 0.55 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 Senescent Cell Mitochondrial DNA Release
Score: 0.54 Retinal Vascular Microcirculation Rescue
Score: 0.54

Related Analyses (30)

CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · completed What delivery mechanisms can achieve therapeutically relevan
drug delivery · failed CRISPR-based therapeutic approaches for neurodegenerative di
neurodegeneration · archived Systemic immune profiling and peripheral immune contribution
neurodegeneration · completed Senescent cell clearance as neurodegeneration therapy
neurodegeneration · completed

Can IGFBPL1 therapeutics effectively cross the blood-brain b
drug delivery · failed How can AQP4 be effectively targeted therapeutically to impr
neurodegeneration · failed What are the specific molecular mechanisms by which AQP4 dys
neurodegeneration · failed How can CNS-selective HDAC/DNMT inhibitors be developed to a
pharmacology · failed Does CXCL10 inhibition compromise CNS immune surveillance du
neuroimmunology · failed How can CRISPR systems achieve persistent therapeutic effect
gene therapy · failed What determines blood-brain barrier penetration kinetics for
neuropharmacology · failed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived

Related Experiments (30)

AECII-specific HMGCS2 overexpression in mouse pulmonary fibr
validation · proposed · Score: 0.95 AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral stud
validation · proposed · Score: 0.90 Proposed experiment from debate on Microglia activate astroc
falsification · proposed · Score: 0.40 Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40 s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.40

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera
validation · proposed · Score: 0.40 AAV-LRRK2 IND-Enabling Study Design
clinical · proposed · Score: 0.40 AAV Serotype Comparison for LRRK2 Knockdown in PD
validation · proposed · Score: 0.40 Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown
validation · proposed · Score: 0.40 AAV-LRRK2 Gene Therapy IND-Enabling Study Design
clinical · proposed · Score: 0.40 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40 Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Synaptic Mitochondrial Resilience Enhancement for Parkinson'
validation · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40 s:** - Biochemical binding assays measuring PROTAC selectivi
falsification · proposed · Score: 0.40 Proposed experiment from debate on Epigenetic clocks and bio
falsification · proposed · Score: 0.40 Proposed experiment from debate on Astrocytes adopt A1 (neur
falsification · proposed · Score: 0.40

See Also (15)

Wnt/β-Catenin Signaling Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses WNK1-Bilirubin Signaling in Neuroinflammation and Neuro
mechanism · Pages share 139 hypotheses vip-vasoactive-intestinal-peptide-signaling-neurodegene
mechanism · Pages share 139 hypotheses VEGF Signaling and Cerebral Angiogenesis in Neurodegene
mechanism · Pages share 139 hypotheses Vagus Nerve Pathway in Neurodegeneration
mechanism · Pages share 139 hypotheses

Ubiquitin-Proteasome System Dysfunction in Neurodegener
mechanism · Pages share 139 hypotheses ubiquitin-proteasome-dysfunction-neurodegeneration
mechanism · Pages share 139 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 139 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 139 hypotheses Tertiary Lymphoid Organs in Neurodegeneration
mechanism · Pages share 139 hypotheses Tau Kinase Signaling Cascade in Alzheimer's Disease
mechanism · Pages share 37 hypotheses T-Cell Dysfunction in Neurodegeneration
mechanism · Pages share 139 hypotheses Synthetic Lethality and PARP Inhibition in Neurodegener
mechanism · Pages share 139 hypotheses synaptic-vesicle-cycling-neurodegeneration
mechanism · Pages share 139 hypotheses

Knowledge Graph (1 edges)

Aav targets Brain

SciDEX — scidex.ai — Dashboard | Atlas